Published in Clin J Pain on February 01, 2010
Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome. Gastroenterology (2011) 1.22
Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome. Front Pharmacol (2011) 1.06
Sex differences and hormonal modulation of deep tissue pain. Front Neuroendocrinol (2013) 0.97
Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry (2015) 0.96
Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing. J Behav Med (2012) 0.94
An endogenous pain control system is altered in subjects with interstitial cystitis. J Urol (2013) 0.91
Visceral analgesia induced by acute and repeated water avoidance stress in rats: sex difference in opioid involvement. Neurogastroenterol Motil (2012) 0.87
Is the conditioned pain modulation paradigm reliable? A test-retest assessment using the nociceptive withdrawal reflex. PLoS One (2014) 0.84
Conditioned pain modulation in women with irritable bowel syndrome. Biol Res Nurs (2014) 0.83
Sex differences in the relationship between maternal fear of pain and children's conditioned pain modulation. J Pain Res (2013) 0.83
Endogenous inhibition of somatic pain is impaired in girls with irritable bowel syndrome compared with healthy girls. J Pain (2013) 0.82
A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity. J Pain (2014) 0.80
Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome. Ann Gastroenterol (2015) 0.78
Visceral pain perception in patients with irritable bowel syndrome and healthy volunteers is affected by the MRI scanner environment. United European Gastroenterol J (2015) 0.78
Abdominal Pain, the Adolescent and Altered Brain Structure and Function. PLoS One (2016) 0.77
Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study. Dig Dis Sci (2014) 0.77
Race Effects on Conditioned Pain Modulation in Youth. J Pain (2015) 0.76
Relationships of abdominal pain, reports to visceral and temperature pain sensitivity, conditioned pain modulation, and heart rate variability in irritable bowel syndrome. Neurogastroenterol Motil (2016) 0.75
Characterizing the longitudinal relations between depressive and menstrual symptoms in adolescent girls. Psychosom Med (2014) 0.75
Impaired conditioned pain modulation in youth with functional abdominal pain. Pain (2016) 0.75
Descending pain modulation in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Syst Rev (2015) 0.75
Chronic morphine increases Fos-positive neurons after concurrent cornea and tail stimulation. Headache (2011) 0.75
The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. J Neurogastroenterol Motil (2017) 0.75
A global measure of perceived stress. J Health Soc Behav (1983) 56.90
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther (1997) 5.78
Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut (1973) 4.28
Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology (1995) 3.95
Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology (1990) 2.75
Idiopathic pain disorders--pathways of vulnerability. Pain (2006) 2.69
Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain (2001) 2.62
Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain (2004) 2.51
Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain (1997) 2.34
Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain (1998) 2.10
Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain (2003) 1.85
Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain (1995) 1.76
Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain (2003) 1.74
Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain (2001) 1.71
Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology (1998) 1.66
Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables. Pain (2003) 1.57
Impairment of pain inhibition in chronic tension-type headache. Pain (2005) 1.41
Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia (2006) 1.34
Mechanisms of disease: pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol (2006) 1.31
Evidence for up-regulated central nociceptive processing in patients with masticatory myofascial pain. J Orofac Pain (2004) 1.26
Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol Fiziol Eksp Ter (1993) 1.25
Catastrophizing is related to pain ratings, but not nociceptive flexion reflex threshold. Pain (2002) 1.14
Relationship between pain sensitivity and resting arterial blood pressure in patients with painful temporomandibular disorders. Psychosom Med (1997) 1.12
Encoding of nociceptive thermal stimuli by diffuse noxious inhibitory controls in humans. J Neurophysiol (1989) 1.12
The influence of resting blood pressure and gender on pain responses. Psychosom Med (1996) 1.08
Counter-stimulatory effects on pain perception and processing are significantly altered by attention: an fMRI study. Neuroreport (2001) 1.06
Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep (2002) 1.04
Diffuse noxious inhibitory controls in man. Involvement of the spinoreticular tract. Brain (1990) 1.03
Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation? Neurogastroenterol Motil (2004) 1.03
Enhancement of the perception of systemic pain in women with vulvar vestibulitis. BJOG (2002) 1.00
A systematic investigation of depression. Compr Psychiatry (1961) 0.97
An evaluation of the measurement of pain catastrophizing by the coping strategies questionnaire. Eur J Pain (2006) 0.96
The association between anger expression and chronic pain intensity: evidence for partial mediation by endogenous opioid dysfunction. Pain (2003) 0.93
The pain inhibiting pain effect: an electrophysiological study in humans. Brain Res (2000) 0.91
Perceptual hyperreactivity to auditory stimuli in patients with irritable bowel syndrome. Scand J Gastroenterol (2000) 0.90
Hypersensitivity to cutaneous thermal nociceptive stimuli in irritable bowel syndrome. Pain (2005) 0.90
[Neurophysiological bases of the counterirritation phenomenon:diffuse control inhibitors induced by nociceptive stimulation]. Neurophysiol Clin (1999) 0.90
Measuring the experience, expression, and control of anger. Issues Compr Pediatr Nurs (1996) 0.89
Effects of experimental and clinical noxious counterirritants on pain perception. Pain (1994) 0.87
Importance of anti- and pro-nociceptive mechanisms in human disease. Gut (2004) 0.87
Counter irritation test in primary fibromyalgia. Clin Rheumatol (1994) 0.82
Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance. Eur J Gastroenterol Hepatol (2001) 0.79
Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of oddi dysfunction, type III. Dig Dis Sci (1999) 0.78
Prevalence of symptomatic pelvic floor disorders in US women. JAMA (2008) 7.81
AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache (2014) 4.25
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology (2003) 3.77
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med (2006) 3.38
Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology (2006) 2.98
Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol (2011) 2.83
Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain (2006) 2.75
Idiopathic pain disorders--pathways of vulnerability. Pain (2006) 2.69
Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects. Exp Physiol (2013) 2.67
Design of treatment trials for functional gastrointestinal disorders. Gastroenterology (2006) 2.58
Perceived intensity and unpleasantness of cutaneous and auditory stimuli: an evaluation of the generalized hypervigilance hypothesis. Pain (2009) 2.55
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell (2010) 2.37
Endoscopic third ventriculostomy and choroid plexus cauterization in infants with hydrocephalus: a retrospective Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr (2014) 2.27
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med (2012) 2.25
Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum (2009) 2.24
Influence of a "warm touch" support enhancement intervention among married couples on ambulatory blood pressure, oxytocin, alpha amylase, and cortisol. Psychosom Med (2008) 2.24
Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol (2010) 2.12
Fetoscopic Repair of Meningomyelocele. Obstet Gynecol (2015) 2.07
Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology (2005) 2.05
"Keystone" approach for intracranial nasofrontal dermoid sinuses. Plast Reconstr Surg (2005) 1.89
Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol (2008) 1.85
Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol (2004) 1.82
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A (2010) 1.79
Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation (2006) 1.79
Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact. Psychosom Med (2005) 1.74
Publication patterns of oral and poster presentations at the annual meetings of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons. J Neurosurg (2011) 1.73
Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome. J Virol (2011) 1.73
IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol (2011) 1.72
Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum (2007) 1.69
Risk factors for fecal incontinence in older women. Am J Gastroenterol (2012) 1.64
Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.63
Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet (2008) 1.59
Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain (2006) 1.57
Cognitive-behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms. Am J Gastroenterol (2010) 1.54
Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study. J Pain (2011) 1.52
Posterior reversible encephalopathy syndrome during posterior fossa tumor resection in a child. J Neurosurg Pediatr (2010) 1.52
Computed tomography morphometric analysis for C-1 lateral mass screw placement in children. Clinical article. J Neurosurg Pediatr (2009) 1.52
Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 1.50
Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. J Pain (2011) 1.50
Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J Pain (2011) 1.48
Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression. PLoS One (2013) 1.48
Genetic architecture of human pain perception. Trends Genet (2007) 1.48
Cigarette smoking, stress-induced analgesia and pain perception in men and women. Pain (2005) 1.47
Intraoperative monitoring of motor evoked potentials in very young children. J Neurosurg Pediatr (2011) 1.46
Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.45
Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol (2007) 1.44
Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. Cell Signal (2006) 1.44
Management of shunt infections: a multicenter pilot study. J Neurosurg (2006) 1.43
Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence. Dis Colon Rectum (2005) 1.43
Effectiveness of a clinical pathway for patients with cerebrospinal fluid shunt malfunction. J Neurosurg Pediatr (2010) 1.40
Temporomandibular disorder and comorbid pain conditions. J Am Dent Assoc (2011) 1.40
Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J Pain (2009) 1.40
Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci (2004) 1.39
Extracranial traumatic carotid artery dissections in children: a review of current diagnosis and treatment options. J Neurosurg Pediatr (2008) 1.39
African Americans show alterations in endogenous pain regulatory mechanisms and reduced pain tolerance to experimental pain procedures. Psychosom Med (2005) 1.34
Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med (2008) 1.33
Validation of a measure of protective parent responses to children's pain. Clin J Pain (2006) 1.31
Fecal incontinence in primary care: prevalence, diagnosis, and health care utilization. Am J Obstet Gynecol (2010) 1.29
Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol (2008) 1.29
Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci (2002) 1.28
Routine imaging in patients with ventriculopleural shunts: lessons learned from a case of tension hydrothorax. J Neurosurg Pediatr (2008) 1.27
Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study. Pharmacogenet Genomics (2010) 1.25
A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus. J Neurosurg Pediatr (2009) 1.25
Associations of abdominal fat with perceived racism and passive emotional responses to racism in African American women. Am J Public Health (2007) 1.24
Associations among four modalities of experimental pain in women. J Pain (2005) 1.22
Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology (2007) 1.22
Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD. Pain (2002) 1.21
Social correlates of the chronic stress of perceived racism among Black women. Ethn Dis (2006) 1.20
Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol (2009) 1.20
Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. J Pain (2009) 1.20
Bowel symptoms in women 1 year after sacrocolpopexy. Am J Obstet Gynecol (2007) 1.19
Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain (2013) 1.18
Biofeedback treatment of constipation: a critical review. Dis Colon Rectum (2003) 1.17
Catastrophizing and Parental Response to Child Symptom Complaints. Child Health Care (2009) 1.16
Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med (2007) 1.15
Computed tomography morphometric analysis for translaminar screw fixation in the upper thoracic spine of the pediatric population. J Neurosurg Pediatr (2011) 1.14
Anorectal functional testing: review of collective experience. Am J Gastroenterol (2002) 1.13
Study protocol, sample characteristics, and loss to follow-up: the OPPERA prospective cohort study. J Pain (2013) 1.12
General health status and incidence of first-onset temporomandibular disorder: the OPPERA prospective cohort study. J Pain (2013) 1.11
Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology (2009) 1.11
Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol (2006) 1.11
Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study. J Pain (2013) 1.08
Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain (2010) 1.08
The phenotypic and genetic signatures of common musculoskeletal pain conditions. Nat Rev Rheumatol (2013) 1.08
Social relationships and health: is feeling positive, negative, or both (ambivalent) about your social ties related to telomeres? Health Psychol (2012) 1.08
Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. J Psychosom Res (2013) 1.07
Relationship between the decision to take a child to the clinic for abdominal pain and maternal psychological distress. Arch Pediatr Adolesc Med (2006) 1.07
Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome. J Gastroenterol Hepatol (2012) 1.07
Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study. J Pain (2013) 1.06
A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol Pain (2010) 1.05
Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study. J Pain (2013) 1.05
Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology (2010) 1.05